• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Section Contents Menu

Newsroom


FDA STATEMENT


For Immediate Release: Dec. 14, 2011
Media Inquiries: Michelle Bolek, 301-796-2973, Michelle.Bolek@fda.hhs.gov
Trade Press Inquiries: Kara Henschel, 301-796-9353, Kara.Henschel@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA


FDA Statement on the Institute of Medicine Report: Scientific Standards for Studies on Modified Risk Tobacco Products


Today, the Institute of Medicine released a report on the design and conduct of studies which the FDA will take into consideration in the assessment and ongoing review of modified risk tobacco products. A modified risk tobacco product is any tobacco product sold or distributed for use to lower the harm or risk of tobacco-related disease associated with other tobacco products.

This report adds to comments and recommendations submitted to the FDA on this topic, including information obtained from a public workshop in August 2011 and an associated open public docket. Experts within the FDA’s Center for Tobacco Products will take these recommendations into consideration in developing its guidance and/or regulation on the scientific evidence required for the assessment and ongoing review of modified risk tobacco products.

The 2009 Family Smoking Prevention and Tobacco Control Act requires the FDA to consult with the IOM on the design and conduct of studies and surveillance required for the assessment and ongoing review of modified risk tobacco products. The FDA must publish regulations and/or guidance on the scientific evidence required for assessment and ongoing review of modified risk tobacco products by April 2012.

For more information:

#

 

Visit the FDA on Facebook 
 

RSS Feed for FDA News Releases [what is RSS?]